Thromboembolic risk with IVIg: Incidence and risk factors in patients with inflammatory neuropathy

Our objective was to evaluate whether IV immunoglobulin (IVIg) increases the risk of thromboembolic events in neurology outpatients with inflammatory neuropathies, as there is conflicting evidence supporting this hypothesis, mainly from non-neurologic cohorts. We investigated this question over 30 m...

Descripción completa

Detalles Bibliográficos
Autores principales: Kapoor, Mahima, Spillane, Jennifer, Englezou, Christina, Sarri-Gonzalez, Scherezade, Bell, Robert, Rossor, Alexander, Manji, Hadi, Reilly, Mary M., Lunn, Michael P., Carr, Aisling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136065/
https://www.ncbi.nlm.nih.gov/pubmed/31852814
http://dx.doi.org/10.1212/WNL.0000000000008742

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136065/
https://www.ncbi.nlm.nih.gov/pubmed/31852814
http://dx.doi.org/10.1212/WNL.0000000000008742

Ejemplares similares